APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Losartan and Hydrochlorothiazide Tablets

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Losartan and Hydrochlorothiazide Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 17400904032 January 2026180 pages

Choose your research edition.

Industry ResearchLosartan and Hydrochlorothiazide Tablets Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Losartan and Hydrochlorothiazide Tablets Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Losartan and Hydrochlorothiazide Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Losartan and Hydrochlorothiazide Tablets Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Losartan and Hydrochlorothiazide Tablets Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Losartan and Hydrochlorothiazide Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Losartan and Hydrochlorothiazide Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Losartan and Hydrochlorothiazide Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Losartan and Hydrochlorothiazide Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Losartan and Hydrochlorothiazide Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Losartan and Hydrochlorothiazide Tablets include Alembic, Aurobindo, Cadista, Lupin, Rising Pharmaceuticals, Torrent, Merck, Sandoz and Teva, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Losartan and Hydrochlorothiazide Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Losartan and Hydrochlorothiazide Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Losartan and Hydrochlorothiazide Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Losartan and Hydrochlorothiazide Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Losartan and Hydrochlorothiazide Tablets Segment by Company

Alembic

Aurobindo

Cadista

Lupin

Rising Pharmaceuticals

Torrent

Merck

Sandoz

Teva

Losartan and Hydrochlorothiazide Tablets Segment by Type

50 mg/ 12.5 mg

100 mg/ 25 mg

Losartan and Hydrochlorothiazide Tablets Segment by Application

Clinics

Hospital

Recovery Center

Losartan and Hydrochlorothiazide Tablets Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Losartan and Hydrochlorothiazide Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Losartan and Hydrochlorothiazide Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Losartan and Hydrochlorothiazide Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Losartan and Hydrochlorothiazide Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Losartan and Hydrochlorothiazide Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Losartan and Hydrochlorothiazide Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Losartan and Hydrochlorothiazide Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Losartan and Hydrochlorothiazide Tablets Industry Trends Table 2. Losartan and Hydrochlorothiazide Tablets Industry Drivers Table 3. Losartan and Hydrochlorothiazide Tablets Industry Opportunities and Challenges Table 4. Losartan and Hydrochlorothiazide Tablets Industry Restraints Table 5. Global Losartan and Hydrochlorothiazide Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Losartan and Hydrochlorothiazide Tablets Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Losartan and Hydrochlorothiazide Tablets Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Losartan and Hydrochlorothiazide Tablets Sales Market Share by Manufacturers Table 9. Global Losartan and Hydrochlorothiazide Tablets Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Losartan and Hydrochlorothiazide Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Losartan and Hydrochlorothiazide Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Losartan and Hydrochlorothiazide Tablets Manufacturers, Product Type & Application Table 13. Global Losartan and Hydrochlorothiazide Tablets Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Losartan and Hydrochlorothiazide Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 50 mg/ 12.5 mg Table 17. Major Manufacturers of 100 mg/ 25 mg Table 18. Global Losartan and Hydrochlorothiazide Tablets Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Losartan and Hydrochlorothiazide Tablets Sales by Type (2021-2026) & (K Units) Table 20. Global Losartan and Hydrochlorothiazide Tablets Sales by Type (2027-2032) & (K Units) Table 21. Global Losartan and Hydrochlorothiazide Tablets Sales Market Share by Type (2021-2026) Table 22. Global Losartan and Hydrochlorothiazide Tablets Sales Market Share by Type (2027-2032) Table 23. Global Losartan and Hydrochlorothiazide Tablets Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Losartan and Hydrochlorothiazide Tablets Revenue by Type (2021-2026) & (K Units) Table 25. Global Losartan and Hydrochlorothiazide Tablets Revenue by Type (2027-2032) & (K Units) Table 26. Global Losartan and Hydrochlorothiazide Tablets Revenue Market Share by Type (2021-2026) Table 27. Global Losartan and Hydrochlorothiazide Tablets Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Clinics Table 29. Major Manufacturers of Hospital Table 30. Major Manufacturers of Recovery Center Table 31. Global Losartan and Hydrochlorothiazide Tablets Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Losartan and Hydrochlorothiazide Tablets Sales by Application (2021-2026) & (K Units) Table 33. Global Losartan and Hydrochlorothiazide Tablets Sales by Application (2027-2032) & (K Units) Table 34. Global Losartan and Hydrochlorothiazide Tablets Sales Market Share by Application (2021-2026) Table 35. Global Losartan and Hydrochlorothiazide Tablets Sales Market Share by Application (2027-2032) Table 36. Global Losartan and Hydrochlorothiazide Tablets Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Losartan and Hydrochlorothiazide Tablets Revenue by Application (2021-2026) & (K Units) Table 38. Global Losartan and Hydrochlorothiazide Tablets Revenue by Application (2027-2032) & (K Units) Table 39. Global Losartan and Hydrochlorothiazide Tablets Revenue Market Share by Application (2021-2026) Table 40. Global Losartan and Hydrochlorothiazide Tablets Revenue Market Share by Application (2027-2032) Table 41. Global Losartan and Hydrochlorothiazide Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Losartan and Hydrochlorothiazide Tablets Sales by Region (2021-2026) & (K Units) Table 43. Global Losartan and Hydrochlorothiazide Tablets Sales Market Share by Region (2021-2026) Table 44. Global Losartan and Hydrochlorothiazide Tablets Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Losartan and Hydrochlorothiazide Tablets Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Losartan and Hydrochlorothiazide Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Losartan and Hydrochlorothiazide Tablets Sales by Country (2021-2026) & (K Units) Table 48. North America Losartan and Hydrochlorothiazide Tablets Sales by Country (2027-2032) & (K Units) Table 49. Europe Losartan and Hydrochlorothiazide Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Losartan and Hydrochlorothiazide Tablets Sales by Country (2021-2026) & (K Units) Table 51. Europe Losartan and Hydrochlorothiazide Tablets Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Losartan and Hydrochlorothiazide Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Losartan and Hydrochlorothiazide Tablets Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Losartan and Hydrochlorothiazide Tablets Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Losartan and Hydrochlorothiazide Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Losartan and Hydrochlorothiazide Tablets Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Losartan and Hydrochlorothiazide Tablets Sales by Country (2027-2032) & (K Units) Table 58. Global Losartan and Hydrochlorothiazide Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Losartan and Hydrochlorothiazide Tablets Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Losartan and Hydrochlorothiazide Tablets Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Losartan and Hydrochlorothiazide Tablets Revenue Market Share by Region (2021-2026) Table 62. Global Losartan and Hydrochlorothiazide Tablets Revenue Market Share by Region (2027-2032) Table 63. Alembic Company Information Table 64. Alembic Business Overview Table 65. Alembic Losartan and Hydrochlorothiazide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Alembic Losartan and Hydrochlorothiazide Tablets Product Portfolio Table 67. Alembic Recent Development Table 68. Aurobindo Company Information Table 69. Aurobindo Business Overview Table 70. Aurobindo Losartan and Hydrochlorothiazide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Aurobindo Losartan and Hydrochlorothiazide Tablets Product Portfolio Table 72. Aurobindo Recent Development Table 73. Cadista Company Information Table 74. Cadista Business Overview Table 75. Cadista Losartan and Hydrochlorothiazide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Cadista Losartan and Hydrochlorothiazide Tablets Product Portfolio Table 77. Cadista Recent Development Table 78. Lupin Company Information Table 79. Lupin Business Overview Table 80. Lupin Losartan and Hydrochlorothiazide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Lupin Losartan and Hydrochlorothiazide Tablets Product Portfolio Table 82. Lupin Recent Development Table 83. Rising Pharmaceuticals Company Information Table 84. Rising Pharmaceuticals Business Overview Table 85. Rising Pharmaceuticals Losartan and Hydrochlorothiazide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Rising Pharmaceuticals Losartan and Hydrochlorothiazide Tablets Product Portfolio Table 87. Rising Pharmaceuticals Recent Development Table 88. Torrent Company Information Table 89. Torrent Business Overview Table 90. Torrent Losartan and Hydrochlorothiazide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Torrent Losartan and Hydrochlorothiazide Tablets Product Portfolio Table 92. Torrent Recent Development Table 93. Merck Company Information Table 94. Merck Business Overview Table 95. Merck Losartan and Hydrochlorothiazide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Merck Losartan and Hydrochlorothiazide Tablets Product Portfolio Table 97. Merck Recent Development Table 98. Sandoz Company Information Table 99. Sandoz Business Overview Table 100. Sandoz Losartan and Hydrochlorothiazide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Sandoz Losartan and Hydrochlorothiazide Tablets Product Portfolio Table 102. Sandoz Recent Development Table 103. Teva Company Information Table 104. Teva Business Overview Table 105. Teva Losartan and Hydrochlorothiazide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Teva Losartan and Hydrochlorothiazide Tablets Product Portfolio Table 107. Teva Recent Development Table 108. Key Raw Materials Table 109. Raw Materials Key Suppliers Table 110. Losartan and Hydrochlorothiazide Tablets Distributors List Table 111. Losartan and Hydrochlorothiazide Tablets Customers List Table 112. Research Programs/Design for This Report Table 113. Authors List of This Report Table 114. Secondary Sources Table 115. Primary Sources List of Figures Figure 1. Losartan and Hydrochlorothiazide Tablets Product Image Figure 2. Global Losartan and Hydrochlorothiazide Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Losartan and Hydrochlorothiazide Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Losartan and Hydrochlorothiazide Tablets Sales (2021-2032) & (K Units) Figure 5. Global Losartan and Hydrochlorothiazide Tablets Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Losartan and Hydrochlorothiazide Tablets Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 50 mg/ 12.5 mg Image Figure 9. 100 mg/ 25 mg Image Figure 10. Global Losartan and Hydrochlorothiazide Tablets Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Losartan and Hydrochlorothiazide Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Losartan and Hydrochlorothiazide Tablets Sales Market Share by Type (2021-2032) Figure 13. Global Losartan and Hydrochlorothiazide Tablets Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Losartan and Hydrochlorothiazide Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Losartan and Hydrochlorothiazide Tablets Revenue Market Share by Type (2021-2032) Figure 16. Clinics Image Figure 17. Hospital Image Figure 18. Recovery Center Image Figure 19. Global Losartan and Hydrochlorothiazide Tablets Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Losartan and Hydrochlorothiazide Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Losartan and Hydrochlorothiazide Tablets Sales Market Share by Application (2021-2032) Figure 22. Global Losartan and Hydrochlorothiazide Tablets Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Losartan and Hydrochlorothiazide Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Losartan and Hydrochlorothiazide Tablets Revenue Market Share by Application (2021-2032) Figure 25. North America Losartan and Hydrochlorothiazide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Losartan and Hydrochlorothiazide Tablets Sales Market Share by Country (2021-2032) Figure 27. U.S. Losartan and Hydrochlorothiazide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Losartan and Hydrochlorothiazide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Losartan and Hydrochlorothiazide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Losartan and Hydrochlorothiazide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Losartan and Hydrochlorothiazide Tablets Sales Market Share by Country (2021-2032) Figure 32. Germany Losartan and Hydrochlorothiazide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Losartan and Hydrochlorothiazide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Losartan and Hydrochlorothiazide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Losartan and Hydrochlorothiazide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Losartan and Hydrochlorothiazide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Losartan and Hydrochlorothiazide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Losartan and Hydrochlorothiazide Tablets Sales Market Share by Country (2021-2032) Figure 39. China Losartan and Hydrochlorothiazide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Losartan and Hydrochlorothiazide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Losartan and Hydrochlorothiazide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Losartan and Hydrochlorothiazide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Losartan and Hydrochlorothiazide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Losartan and Hydrochlorothiazide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Losartan and Hydrochlorothiazide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Losartan and Hydrochlorothiazide Tablets Sales Market Share by Country (2021-2032) Figure 47. Brazil Losartan and Hydrochlorothiazide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Losartan and Hydrochlorothiazide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Losartan and Hydrochlorothiazide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Losartan and Hydrochlorothiazide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Losartan and Hydrochlorothiazide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Losartan and Hydrochlorothiazide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Losartan and Hydrochlorothiazide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Losartan and Hydrochlorothiazide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Losartan and Hydrochlorothiazide Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Losartan and Hydrochlorothiazide Tablets Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Losartan and Hydrochlorothiazide Tablets Revenue (2021-2032) & (US$ Million) Figure 58. North America Losartan and Hydrochlorothiazide Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Losartan and Hydrochlorothiazide Tablets Revenue (2021-2032) & (US$ Million) Figure 60. Europe Losartan and Hydrochlorothiazide Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Losartan and Hydrochlorothiazide Tablets Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Losartan and Hydrochlorothiazide Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Losartan and Hydrochlorothiazide Tablets Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Losartan and Hydrochlorothiazide Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Losartan and Hydrochlorothiazide Tablets Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Losartan and Hydrochlorothiazide Tablets Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • 50 mg/ 12.5 mg
  • 100 mg/ 25 mg
Applications
  • Clinics
  • Hospital
  • Recovery Center
Companies covered
  • Alembic
  • Aurobindo
  • Cadista
  • Lupin
  • Rising Pharmaceuticals
  • Torrent
  • Merck
  • Sandoz
  • Teva

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Losartan and Hydrochlorothiazide Tablets Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Losartan and Hydrochlorothiazide Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Losartan and Hydrochlorothiazide Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Losartan and Hydrochlorothiazide Tablets Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Losartan and Hydrochlorothiazide Tablets Market Dynamics
  1. 2.1 Losartan and Hydrochlorothiazide Tablets Industry Trends
  2. 2.2 Losartan and Hydrochlorothiazide Tablets Industry Drivers
  3. 2.3 Losartan and Hydrochlorothiazide Tablets Industry Opportunities and Challenges
  4. 2.4 Losartan and Hydrochlorothiazide Tablets Industry Restraints
3 Losartan and Hydrochlorothiazide Tablets Market by Manufacturers
  1. 3.1 Global Losartan and Hydrochlorothiazide Tablets Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Losartan and Hydrochlorothiazide Tablets Sales by Manufacturers (2021-2026)
  3. 3.3 Global Losartan and Hydrochlorothiazide Tablets Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Losartan and Hydrochlorothiazide Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Losartan and Hydrochlorothiazide Tablets Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Losartan and Hydrochlorothiazide Tablets Manufacturers, Product Type & Application
  7. 3.7 Global Losartan and Hydrochlorothiazide Tablets Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Losartan and Hydrochlorothiazide Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Losartan and Hydrochlorothiazide Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Losartan and Hydrochlorothiazide Tablets Tier 1, Tier 2, and Tier 3
4 Losartan and Hydrochlorothiazide Tablets Market by Type
  1. 4.1 Losartan and Hydrochlorothiazide Tablets Type Introduction
  2. 4.1.1 50 mg/ 12.5 mg
  3. 4.1.2 100 mg/ 25 mg
  4. 4.2 Global Losartan and Hydrochlorothiazide Tablets Sales by Type
  5. 4.2.1 Global Losartan and Hydrochlorothiazide Tablets Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Losartan and Hydrochlorothiazide Tablets Sales by Type (2021-2032)
  7. 4.2.3 Global Losartan and Hydrochlorothiazide Tablets Sales Market Share by Type (2021-2032)
  8. 4.3 Global Losartan and Hydrochlorothiazide Tablets Revenue by Type
  9. 4.3.1 Global Losartan and Hydrochlorothiazide Tablets Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Losartan and Hydrochlorothiazide Tablets Revenue by Type (2021-2032)
  11. 4.3.3 Global Losartan and Hydrochlorothiazide Tablets Revenue Market Share by Type (2021-2032)
5 Losartan and Hydrochlorothiazide Tablets Market by Application
  1. 5.1 Losartan and Hydrochlorothiazide Tablets Application Introduction
  2. 5.1.1 Clinics
  3. 5.1.2 Hospital
  4. 5.1.3 Recovery Center
  5. 5.2 Global Losartan and Hydrochlorothiazide Tablets Sales by Application
  6. 5.2.1 Global Losartan and Hydrochlorothiazide Tablets Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Losartan and Hydrochlorothiazide Tablets Sales by Application (2021-2032)
  8. 5.2.3 Global Losartan and Hydrochlorothiazide Tablets Sales Market Share by Application (2021-2032)
  9. 5.3 Global Losartan and Hydrochlorothiazide Tablets Revenue by Application
  10. 5.3.1 Global Losartan and Hydrochlorothiazide Tablets Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Losartan and Hydrochlorothiazide Tablets Revenue by Application (2021-2032)
  12. 5.3.3 Global Losartan and Hydrochlorothiazide Tablets Revenue Market Share by Application (2021-2032)
6 Global Losartan and Hydrochlorothiazide Tablets Sales by Region
  1. 6.1 Global Losartan and Hydrochlorothiazide Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Losartan and Hydrochlorothiazide Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Losartan and Hydrochlorothiazide Tablets Sales by Region (2021-2026)
  4. 6.2.2 Global Losartan and Hydrochlorothiazide Tablets Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Losartan and Hydrochlorothiazide Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Losartan and Hydrochlorothiazide Tablets Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Losartan and Hydrochlorothiazide Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Losartan and Hydrochlorothiazide Tablets Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Losartan and Hydrochlorothiazide Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Losartan and Hydrochlorothiazide Tablets Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Losartan and Hydrochlorothiazide Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Losartan and Hydrochlorothiazide Tablets Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Losartan and Hydrochlorothiazide Tablets Revenue by Region
  1. 7.1 Global Losartan and Hydrochlorothiazide Tablets Revenue by Region
  2. 7.1.1 Global Losartan and Hydrochlorothiazide Tablets Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Losartan and Hydrochlorothiazide Tablets Revenue by Region (2021-2026)
  4. 7.1.3 Global Losartan and Hydrochlorothiazide Tablets Revenue by Region (2027-2032)
  5. 7.1.4 Global Losartan and Hydrochlorothiazide Tablets Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Losartan and Hydrochlorothiazide Tablets Revenue (2021-2032)
  8. 7.2.2 North America Losartan and Hydrochlorothiazide Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Losartan and Hydrochlorothiazide Tablets Revenue (2021-2032)
  11. 7.3.2 Europe Losartan and Hydrochlorothiazide Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Losartan and Hydrochlorothiazide Tablets Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Losartan and Hydrochlorothiazide Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Losartan and Hydrochlorothiazide Tablets Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Losartan and Hydrochlorothiazide Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Alembic
  2. 8.1.1 Alembic Company Information
  3. 8.1.2 Alembic Business Overview
  4. 8.1.3 Alembic Losartan and Hydrochlorothiazide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Alembic Losartan and Hydrochlorothiazide Tablets Product Portfolio
  6. 8.1.5 Alembic Recent Developments
  7. 8.2 Aurobindo
  8. 8.2.1 Aurobindo Company Information
  9. 8.2.2 Aurobindo Business Overview
  10. 8.2.3 Aurobindo Losartan and Hydrochlorothiazide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Aurobindo Losartan and Hydrochlorothiazide Tablets Product Portfolio
  12. 8.2.5 Aurobindo Recent Developments
  13. 8.3 Cadista
  14. 8.3.1 Cadista Company Information
  15. 8.3.2 Cadista Business Overview
  16. 8.3.3 Cadista Losartan and Hydrochlorothiazide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Cadista Losartan and Hydrochlorothiazide Tablets Product Portfolio
  18. 8.3.5 Cadista Recent Developments
  19. 8.4 Lupin
  20. 8.4.1 Lupin Company Information
  21. 8.4.2 Lupin Business Overview
  22. 8.4.3 Lupin Losartan and Hydrochlorothiazide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Lupin Losartan and Hydrochlorothiazide Tablets Product Portfolio
  24. 8.4.5 Lupin Recent Developments
  25. 8.5 Rising Pharmaceuticals
  26. 8.5.1 Rising Pharmaceuticals Company Information
  27. 8.5.2 Rising Pharmaceuticals Business Overview
  28. 8.5.3 Rising Pharmaceuticals Losartan and Hydrochlorothiazide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Rising Pharmaceuticals Losartan and Hydrochlorothiazide Tablets Product Portfolio
  30. 8.5.5 Rising Pharmaceuticals Recent Developments
  31. 8.6 Torrent
  32. 8.6.1 Torrent Company Information
  33. 8.6.2 Torrent Business Overview
  34. 8.6.3 Torrent Losartan and Hydrochlorothiazide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Torrent Losartan and Hydrochlorothiazide Tablets Product Portfolio
  36. 8.6.5 Torrent Recent Developments
  37. 8.7 Merck
  38. 8.7.1 Merck Company Information
  39. 8.7.2 Merck Business Overview
  40. 8.7.3 Merck Losartan and Hydrochlorothiazide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Merck Losartan and Hydrochlorothiazide Tablets Product Portfolio
  42. 8.7.5 Merck Recent Developments
  43. 8.8 Sandoz
  44. 8.8.1 Sandoz Company Information
  45. 8.8.2 Sandoz Business Overview
  46. 8.8.3 Sandoz Losartan and Hydrochlorothiazide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Sandoz Losartan and Hydrochlorothiazide Tablets Product Portfolio
  48. 8.8.5 Sandoz Recent Developments
  49. 8.9 Teva
  50. 8.9.1 Teva Company Information
  51. 8.9.2 Teva Business Overview
  52. 8.9.3 Teva Losartan and Hydrochlorothiazide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Teva Losartan and Hydrochlorothiazide Tablets Product Portfolio
  54. 8.9.5 Teva Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Losartan and Hydrochlorothiazide Tablets Value Chain Analysis
  2. 9.1.1 Losartan and Hydrochlorothiazide Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Losartan and Hydrochlorothiazide Tablets Production Mode & Process
  6. 9.2 Losartan and Hydrochlorothiazide Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Losartan and Hydrochlorothiazide Tablets Distributors
  9. 9.2.3 Losartan and Hydrochlorothiazide Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst